Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-08-03 Sale |
2020-08-05 6:47 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
80,000 | $27.23 | $2,178,066 | 7,698,783 (Indirect Direct) |
View |
2020-07-01 Sale |
2020-07-06 7:18 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
143,470 | $30.75 | $4,411,357 | 7,778,783 (Indirect Direct) |
View |
2020-06-08 Sale |
2020-06-10 4:09 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
10,600 | $30.01 | $318,125 | 7,922,253 (Indirect Direct) |
View |
2020-06-03 Sale |
2020-06-05 7:55 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
5,930 | $30.05 | $178,173 | 8,605,473 (Indirect Direct) |
View |
2020-06-01 Sale |
2020-06-03 4:06 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
80,000 | $29.19 | $2,335,390 | 7,938,783 (Indirect Direct) |
View |
2020-05-05 Sale |
2020-05-06 8:21 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
79,600 | $31.02 | $2,469,482 | 8,018,783 (Indirect Direct) |
View |
2020-05-01 Sale |
2020-05-05 4:05 pm |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
80,400 | $29.4 | $2,364,085 | 8,098,383 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2020-06-03 Option Award |
2020-06-05 7:55 pm |
N/A 2030-06-02 |
BridgeBio Pharma Inc. | BBIO | Kumar Neil CEO and President |
672,620 | $0 | 8,605,473 (Direct) |
View |